Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2014-11-28

FDA Approved: MINOXIDIL — Supplemental Application (Endo USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for MINOXIDIL from Endo USA, Inc., updating the labeling for the treatment of androgenetic alopecia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MINOXIDIL (Minoxidil)

Snippet

SUPPL AP for MINOXIDIL (MINOXIDIL)